Sat Kartar Life Limited
NNSE:SATKARTAR137.30
INR
+6.15
(+4.69%)
Sat Kartar Life Limited
NSE:SATKARTAR
(National Stock Exchange of India)
Recent
price
137.30
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Semi-annual Revenue
FRC
•
in mil. unless spec.Semi-annual Earnings Per Share
FRC
•
in mil. unless spec.Semi-annual Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Sat Kartar Life Limited is an India-based integrated Ayurvedic healthcare and wellness company engaged in the formulation, marketing, and distribution of herbal remedies, dietary supplements, and therapeutic personal care solutions. The company operates through an omnichannel and direct-to-consumer (D2C) business model, combining digital commerce platforms, televised marketing, and virtual consultations with developing clinical care infrastructure. Its product portfolio is organized across several core therapeutic categories: addiction management formulations, including herbal powders and liquid drops marketed under the Addiction Killer and Nasha Free brands; diabetes care supplements, including Dr. Madhu Amrit and Ayush 82 Aadved; joint and musculoskeletal pain remedies, including Ortho Veda Oil; digestive and gastrointestinal health solutions, including Vajra 44; sexual wellness and vitality formulations, including Liv Muztang and Kaama Gold; women's health treatments addressing hormonal balance and PCOD; weight management supplements, including Power Rootz SSS Formulae; and general wellness products spanning herbal hair care, skincare, immunity boosters, and dietary vitamins. In addition to physical products, the company offers clinical consultations, telemedicine services, and holistic wellness guidance. Founded in 2012 as Sat Kartar Shopping Private Limited and headquartered in New Delhi, India, the company serves domestic consumers across India and distributes products to international markets including the United States, Canada, the United Kingdom, Australia, the United Arab Emirates, and Southeast Asia. In recent operational developments, the company completed its initial public offering (IPO) and listed on the National Stock Exchange of India (NSE Emerge) under the ticker symbol SATKARTAR in January 2025. In February 2026, the company changed its name from Sat Kartar Shopping Limited to Sat Kartar Life Limited to reflect its broader transition from an e-commerce merchant to an integrated healthcare ecosystem. In May 2026, the company completed the acquisition of US-based subsidiary Plantomed to establish direct commercial operations and expand product distribution in North America. In April 2026, the company entered into a strategic three-year partnership with Jeena Sikho Lifecare Limited to integrate digital patient acquisition technologies with clinical infrastructure and co-develop Ayurvedic hospital facilities in South India. Furthermore, the company expanded into physical healthcare infrastructure through the establishment of a 20-bed hospital and therapy center in Dehradun, Uttarakhand, and diversified its commercial offerings to include curated spiritual wellness products and consultation services.